Truveris
PrivateLast Round
Series E
May 14, 2024
Total Funding Raised
$66.55M
Company Overview
Truveris is a healthcare technology company that provides a pharmacy benefits procurement and insights platform to reduce prescription drug costs.
Sector
Enterprise Software
Verticals
Healthcare Analytics, Pharma Supply Chain, Vertical SaaS, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Marketplace Commission, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truveris Comps
Public and private peers based on sector, stage, and business model.
Truveris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | May 14, 2024 | ||||
| Series D | Sep 6, 2017 | ||||
| Series C | Jun 27, 2014 | ||||
| Series B | Feb 23, 2012 | ||||
| Series A | Feb 1, 2011 |
Key People
Founding team and executive leadership
Truveris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GSA Venture Partners | Series A |
| New Leaf Venture Partners | Series C, Series D, Series E, Series B |
| McKesson Ventures | Series D |
| Canaan Partners | Series D, Series E, Series C |
| First Round Capital | Series C, Series B, Series A |
| NAV.VC | Series C, Series B, Series D, Series A |
| Tribeca Venture Partners | Series C, Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
Monthly visitors grew 43% MoM, reaching 6.3K.
- May 14, 2024
$15M round led by Canaan Partners and New Leaf Venture Partners.
Truveris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Truveris's valuation, stock price, and market status.
